Clinical trial
17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and…
NCT00163020 · Obstetrix Medical Group, Industry · Completed
Key facts
| NCT number | NCT00163020 |
|---|---|
| Title | 17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies |
| Official title | 17-Alpha-Hydroxyprogesterone Caproate for Reduction of Neonatal Morbidity Due to Preterm Birth in Twin and Triplet Pregnancies - A Concurrent Randomized Double-blinded Clinical Trial |
| Acronym | 170HP |
| Lead sponsor | Obstetrix Medical Group, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Preterm Birth |
| Intervention type | Drug |
| Interventions | 17-alpha-hydroxyprogesterone caproate injectable, Placebo |
| Enrollment | 321 |
| Start date | Nov 1, 2004 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Sep 13, 2005 |
| Last update posted | Apr 11, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: